Trials / Unknown

UnknownNCT06238284

HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Status: Unknown
Phase: —
Study type: Observational
Enrollment: 300 (estimated)

Sponsor: Chongqing University Cancer Hospital · Academic / Other
Sex: Female
Age: 18 Years – 75 Years
Healthy volunteers: Not accepted

Summary

This study aims to retrospectively analyze the HER2 expression of gynecological malignant tumors in Chongqing by immunohistochemical detection, and explore the correlation between HER2 level, therapy response and prognosis based on patient clinical information.

Conditions

Cervical Cancer
Endometrial Cancer
Ovarian Cancer
HER2 Expression

Interventions

Type	Name	Description
OTHER	no intervention	Since it is a retrospective study, no intervention is needed.

Timeline

Start date: 2024-01-26
Primary completion: 2024-03-31
Completion: 2024-05-31
First posted: 2024-02-02
Last updated: 2024-02-02

Source: ClinicalTrials.gov record NCT06238284. Inclusion in this directory is not an endorsement.